Kantonsspital Münsterlingen

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Childhood cancers1 trial
• Chronic lymphocytic leukaemia1 trial
• HIV1 trial
• Lung cancer1 trial
• Neuroendocrine tumours1 trial
• Ovarian cancer1 trial
• Prostate cancer1 trial
• Stroke1 trial

Phase

• Phase 33 trials
• Phase 21 trial
• Phase 2/31 trial

Status

• Recruiting3 trials
• Terminated2 trials
• Active, not recruiting1 trial
• Withdrawn1 trial

Lead sponsor

• BioNTech SE1 trial
• Gustave Roussy, Cancer Campus, Grand Paris1 trial
• Insel Gruppe AG, University Hospital Bern1 trial
• Swiss Cancer Institute1 trial
• Swiss GO Trial Group1 trial
• and 2 more

Running trials

• Recruiting

  Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)

  NCT06712316· Phase 2/3· BioNTech SE· Source

• Recruiting

  MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)

  NCT04111978· Phase 3· Swiss GO Trial Group· Source

  Contact: Christian Taverna, Dr. med.

• Active, not recruiting

  Enhancement of Stroke Rehabilitation With Levodopa

  NCT03735901· Phase 3· University Hospital, Basel, Switzerland· Source

• Recruiting

  The SwissPrEPared Study

  NCT03893188· University of Zurich· Source

  Contact: Sabine Majer, MD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• HIV1 recruiting
• Lung cancer1 recruiting
• Ovarian cancer1 recruiting

Closed trials

• Recruiting

  Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer

  NCT03819101· Phase 3· Gustave Roussy, Cancer Campus, Grand Paris· Source

  Contact: Karim Fizazi, MD, PhD

• Terminated

  Ibrutinib lead-in Followed by Venetoclax Plus Ibrutinib in Patients With RR CLL

  NCT03708003· Phase 2· Swiss Cancer Institute· Source

• Terminated

  SwissNET - a Registry for Neuroendocrine Tumours in Switzerland

  NCT01039922· Insel Gruppe AG, University Hospital Bern· Source